1. Home
  2. MEDP

as 12-11-2024 4:00pm EST

$
-
-
-
.
-
-
-
$
-
.
-
-
-
-
.
-
-
%

Stocks

Health Care

Biotechnology: Commercial Physical & Biological Resarch

Nasdaq

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical-device firms. It also offers ancillary services such as bioanalytical laboratory services and imaging capabilities. The company was founded over 30 years ago and has over 5,400 employees across 40 countries. Medpace is headquartered in Cincinnati and its operations are principally based in the us, but it also operates in Europe, Asia, South America, Africa, and Australia. Cinven, a global private equity firm, acquired Medpace for $915 million in 2014 and exited its investment in 2018.

Founded: 1992 Country:
United States
United States
Employees: N/A City: CINCINNATI
Market Cap: 11.7B IPO Year: 2016
Target Price: $389.00 AVG Volume (30 days): 334.5K
Analyst Decision: Buy Number of Analysts: 10
Dividend Yield:
N/A
Dividend Payout Frequency: N/A
EPS: 11.42 EPS Growth: 33.84
52 Week Low/High: $277.72 - $459.77 Next Earning Date: 02-10-2025
Revenue: $2,070,866,000 Revenue Growth: 16.24%
Revenue Growth (this year): 14.01% Revenue Growth (next year): 5.86%

MEDP Daily Stock ML Predictions

Share on Social Networks: